BR9301136A - Oligossacarideo e formulacao farmaceutica - Google Patents

Oligossacarideo e formulacao farmaceutica

Info

Publication number
BR9301136A
BR9301136A BR9301136A BR9301136A BR9301136A BR 9301136 A BR9301136 A BR 9301136A BR 9301136 A BR9301136 A BR 9301136A BR 9301136 A BR9301136 A BR 9301136A BR 9301136 A BR9301136 A BR 9301136A
Authority
BR
Brazil
Prior art keywords
oligosaccharides
oligosacaride
pharmaceutical formulation
cell adhesion
produced
Prior art date
Application number
BR9301136A
Other languages
English (en)
Inventor
Sau-Chi Betty Yan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9301136A publication Critical patent/BR9301136A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Amplifiers (AREA)
BR9301136A 1992-03-12 1993-03-11 Oligossacarideo e formulacao farmaceutica BR9301136A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84986892A 1992-03-12 1992-03-12

Publications (1)

Publication Number Publication Date
BR9301136A true BR9301136A (pt) 1993-09-28

Family

ID=25306715

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9301136A BR9301136A (pt) 1992-03-12 1993-03-11 Oligossacarideo e formulacao farmaceutica

Country Status (23)

Country Link
EP (1) EP0565241B1 (pt)
JP (1) JP3171506B2 (pt)
KR (1) KR930019696A (pt)
CN (1) CN1079967A (pt)
AT (1) ATE137241T1 (pt)
AU (1) AU661762B2 (pt)
BR (1) BR9301136A (pt)
CA (1) CA2091521A1 (pt)
CY (1) CY1947A (pt)
CZ (1) CZ39093A3 (pt)
DE (1) DE69302317T2 (pt)
DK (1) DK0565241T3 (pt)
ES (1) ES2088227T3 (pt)
FI (1) FI931086A (pt)
GR (1) GR3020406T3 (pt)
HK (1) HK132396A (pt)
HU (1) HUT69613A (pt)
IL (1) IL105018A0 (pt)
MX (1) MX9301344A (pt)
NO (1) NO930890L (pt)
NZ (1) NZ247105A (pt)
YU (1) YU16993A (pt)
ZA (1) ZA931723B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE456664T1 (de) * 2001-04-02 2010-02-15 Glycomedics Inc Verfahren zur herstellung von oligosaccharidketten
FI20011664A (fi) 2001-08-17 2003-02-18 Carbion Oy Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
US7943763B2 (en) * 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
WO2004058824A1 (ja) * 2002-12-26 2004-07-15 Otsuka Chemical Co., Ltd. ３分岐型糖鎖アスパラギン誘導体、該糖鎖アスパラギン、該糖鎖およびそれらの製造方法
JP3884725B2 (ja) 2003-06-03 2007-02-21 三菱電機株式会社 導波管装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009889A (en) * 1987-12-31 1991-04-23 Oklahoma Medical Research Foundation Treatment of dysfunctional vascular endothelium using activated protein C

Also Published As

Publication number Publication date
EP0565241B1 (en) 1996-04-24
EP0565241A1 (en) 1993-10-13
AU661762B2 (en) 1995-08-03
ES2088227T3 (es) 1996-08-01
YU16993A (sh) 1996-02-19
GR3020406T3 (en) 1996-09-30
HK132396A (en) 1996-07-26
MX9301344A (es) 1993-09-01
HU9300687D0 (en) 1993-05-28
CA2091521A1 (en) 1993-09-13
DK0565241T3 (da) 1996-05-28
JP3171506B2 (ja) 2001-05-28
DE69302317T2 (de) 1996-09-19
IL105018A0 (en) 1993-07-08
ATE137241T1 (de) 1996-05-15
CN1079967A (zh) 1993-12-29
JPH0625302A (ja) 1994-02-01
CY1947A (en) 1993-03-12
ZA931723B (en) 1994-09-10
NZ247105A (en) 1994-11-25
DE69302317D1 (de) 1996-05-30
FI931086A (fi) 1993-09-13
NO930890L (no) 1993-09-13
HUT69613A (en) 1995-09-28
AU3519993A (en) 1993-09-16
NO930890D0 (no) 1993-03-11
FI931086A0 (fi) 1993-03-11
CZ39093A3 (en) 1994-03-16
KR930019696A (ko) 1993-10-18

Similar Documents

Publication Publication Date Title
ATE199096T1 (de) Il-11 aus säugetier
PT817847E (pt) Receptor de il-17
IT1146723B (it) Complesso antibiotico procedimento per la sua preparazione composizione farmaceutica contenente tale complesso e microorganismo per l attuazione di tale procedimento
AU6541990A (en) Extracellular matrix protein adherent t cells
NO930975L (no) Fuktighetsherdende en-komponent polysiloksanforbindelse
BR9301136A (pt) Oligossacarideo e formulacao farmaceutica
IT1237470B (it) Derivati di imidazolo, procedimenti per produrli e composizioni farmaceutiche che li contengono
AU3927189A (en) N-2,3-butadienyl tri- and tetraaminoalkane derivatives
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
ATE48142T1 (de) Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
WO1990007321A3 (en) Lymphocyte receptor homing sequences and their uses
ES2002915A6 (es) Un procedimiento para la preparacion de un peptido de veneno de serpiente que detiene el crecimiento.
IT1230167B (it) Procedimento per il rivestimento con pellicola di composizioni farmaceutiche con dispersioni di polimeri.
Warfel et al. Macrophage membrane glycoproteins that bind Griffonia simplicifolia I‐B4: Effect on cytotoxicity and protein secretion
RU93004705A (ru) Олигосахариды, фармацевтическая композиция, применение олигосахаридов
Takahama et al. Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and-stimulating activity.
FR2572080B1 (fr) Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
IT8323859A0 (it) Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
IT8721455A0 (it) Composizioni farmaceutiche per la terapia di stati fisiopatologici ad accresciuto catabolismo proteico.
RU94026276A (ru) Рецепторы интерлейкина-12 и антител
IT8919109A0 (it) Composizioni farmaceutiche per la terapia di stati fisiopatologici ad accresciuto catabolismo proteico.

Legal Events

Date Code Title Description
EE Request for examination
FC Decision: refusal
CKFC Appeal: appeal against refusal
B15K Others concerning applications: alteration of classification

Ipc: C07H 13/04 (2006.01), C12N 9/64 (2006.0